U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics

The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.

source https://www.nytimes.com/2023/05/16/business/amgen-horizon-therapeutics-lawsuit.html